Extract
Derma Sciences Raises $29 Million in Private Placement Financing.
Proceeds to Be Used to Advance DSC127 into Phase 3 Trials in Diabetic Foot Ulcers and for New Sales Representatives for Advanced Wound Care Products
PRINCETON, N.J. -- Derma Sciences, Inc. ("Derma Sciences" or "the Company") (Nasdaq: DSCI), a medical device and pharmaceutical company focused on a...See the full content of this document
Sponsored links
